SINGAPORE, April 25, 2025 /PRNewswire/ — World-leading engine manufacturer Weichai has received the 2025 Manufacturing Award at the Singapore Business Review (SBR) International Business Awards. The accolade recognizes the company’s breakthroughs in thermal efficiency and cross-border collaboration in green manufacturing transformation.
Weichai has long focused on enhancing the efficiency of internal combustion engines. In April 2024, it set a new global benchmark by achieving 53.09% thermal efficiency in its diesel engine — the highest ever recorded in the industry. Technical experts view this milestone as a critical step toward practical emissions reduction in heavy-duty applications.
In parallel with efficiency gains, Weichai is accelerating its exploration of clean energy pathways. In 2024, it launched Singapore’s first long-term maritime trial using B100 biodiesel. Operated within the Port of Singapore, the trial marks a strategic step towards decarbonizing the maritime sector. Company representatives noted that the biodiesel initiative is not merely a technical validation, but a proactive alignment with the global net-zero agenda in shipping.
As Singapore accelerates its transition into a green, low-carbon manufacturing hub — Weichai is advancing collaborative R&D with institutions such as Nanyang Technological University. Its ongoing research all designed to align with Singapore’s carbon neutrality roadmap.
“This recognition underscores Weichai’s role as a technological partner in regional low-carbon transformation,” said the company’s technical manager. “Our innovations are powering the next generation of green infrastructure.”
Industry analysts believe Weichai’s dual progress in thermal efficiency and clean fuels offers a scalable Chinese solution for the Asia-Pacific region’s green industrial transformation.
ข่าวที่เกี่ยวข้อง
- Xinhua Silk Road: Jing’an District promotes investment opportunities, global business cooperation at 2026 CIIE
- Binance Blockchain Week Bangkok 2026 Unveils First Wave of Speakers, Spotlighting the Convergence of Traditional Finance and Digital Assets
- Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral Small Molecule Fixed-Dose Combination of GLP-1R Agonist and Selective Amylin Receptor Agonist, for the Treatment of Obesity
- Ali Y. Koç: ‘The Energy Transition Has Become the Cornerstone of Competitiveness in Industry’
